Recent Quarter Total Invested
$55.25 M
Recent Quarter Institutional Ownership Percentage
75.4%
Total Invested of Last Quarter
$54.79 M
Ownership Percentage of Last Quarter
79.87%
Eagle Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
NANTAHALA CAPITAL MANAGEMENT, LLC | 08/20/2024 | 1.96 M | $10.99 M | 55.87% | 14.99% |
AIGH CAPITAL MANAGEMENT LLC | 08/07/2024 | 1.21 M | $6.78 M | 2.11% | 9.25% |
CITIGROUP INC | 08/12/2024 | 1.00 M | $5.61 M | 36,748.97% | 7.65% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 08/20/2024 | 1.00 M | $5.60 M | 100.00% | 7.64% |
AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 696,797 | $3.90 M | -20.74% | 5.32% |
VANGUARD GROUP INC | 08/13/2024 | 564,396 | $3.16 M | -11.92% | 4.31% |
BLACKROCK INC. | 08/13/2024 | 352,762 | $1.98 M | -60.71% | 2.69% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 325,519 | $1.82 M | 0.00% | 2.49% |
MORGAN STANLEY | 08/14/2024 | 300,448 | $1.68 M | -19.95% | 2.30% |
LSV ASSET MANAGEMENT | 08/06/2024 | 295,388 | $1.65 M | -11.60% | 2.26% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 244,250 | $1.37 M | -26.84% | 1.87% |
TWO SIGMA ADVISERS, LP | 08/14/2024 | 224,817 | $1.26 M | -4.87% | 1.72% |
MARSHALL WACE, LLP | 08/14/2024 | 195,475 | $1.09 M | -24.08% | 1.49% |
J. GOLDMAN & CO LP | 08/14/2024 | 191,111 | $1.07 M | -26.13% | 1.46% |
ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 185,337 | $1.04 M | 0.00% | 1.42% |
PERCEPTIVE ADVISORS LLC | 08/16/2024 | 173,365 | $970,844 | 100.00% | 1.32% |
D. E. SHAW & CO., INC. | 08/14/2024 | 171,008 | $957,645 | -22.20% | 1.31% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 167,782 | $939,579 | -34.93% | 1.28% |
TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 133,944 | $750,086 | -18.04% | 1.02% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 08/05/2024 | 132,606 | $742,594 | -30.84% | 1.01% |
RBF CAPITAL, LLC | 08/14/2024 | 128,087 | $717,287 | 100.00% | 0.98% |
TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 118,857 | $665,599 | 0.00% | 0.91% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 108,004 | $604,976 | -53.37% | 0.83% |
NORTHERN TRUST CORP | 08/14/2024 | 94,062 | $526,747 | -5.47% | 0.72% |
INVESCO LTD. | 08/13/2024 | 82,424 | $461,574 | -29.70% | 0.63% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 79,093 | $442,921 | -55.52% | 0.60% |
TREXQUANT INVESTMENT LP | 08/13/2024 | 52,953 | $296,537 | -40.80% | 0.40% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 50,589 | $283,298 | -31.57% | 0.39% |
DEUTSCHE BANK AG\ | 08/14/2024 | 48,800 | $273,280 | 0.00% | 0.37% |
ROYAL BANK OF CANADA | 08/14/2024 | 37,601 | $211,000 | 33.55% | 0.29% |
STATE STREET CORP | 08/14/2024 | 35,820 | $200,592 | -83.24% | 0.27% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 31,900 | $178,640 | 0.00% | 0.24% |
PDT PARTNERS, LLC | 08/15/2024 | 30,011 | $168,062 | 10.91% | 0.23% |
FMR LLC | 08/13/2024 | 29,163 | $163,313 | 31.94% | 0.22% |
ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 26,390 | $147,000 | -49.68% | 0.20% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 09/16/2024 | 25,812 | $144,546 | 100.00% | 0.20% |
BANK OF MONTREAL /CAN/ | 08/14/2024 | 24,696 | $138,298 | -3.88% | 0.19% |
BNP PARIBAS ARBITRAGE, SNC | 08/13/2024 | 24,402 | $136,651 | -34.73% | 0.19% |
GREAT LAKES ADVISORS, LLC | 08/06/2024 | 23,622 | $132,283 | 108.18% | 0.18% |
ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 22,000 | $123,200 | 100.00% | 0.17% |
XTX TOPCO LTD | 08/12/2024 | 20,204 | $113,142 | 100.00% | 0.15% |
BARCLAYS PLC | 08/14/2024 | 19,109 | $107,000 | -15.41% | 0.15% |
SQUAREPOINT OPS LLC | 08/14/2024 | 17,825 | $99,820 | 100.00% | 0.14% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 16,763 | $93,872 | 372.06% | 0.13% |
ROYCE & ASSOCIATES LP | 08/13/2024 | 13,821 | $77,398 | 0.00% | 0.11% |
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 08/12/2024 | 13,629 | $76,322 | 100.00% | 0.10% |
PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 13,300 | $75,000 | -15.54% | 0.10% |
HSBC HOLDINGS PLC | 08/12/2024 | 13,148 | $66,266 | -0.22% | 0.10% |
BLAIR WILLIAM & CO/IL | 08/12/2024 | 13,100 | $73,360 | -7.42% | 0.10% |
FIDELIS CAPITAL PARTNERS, LLC | 08/13/2024 | 12,762 | $54,239 | 100.00% | 0.10% |
Eagle Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of EGRX shares?
During the previous two years, 166 institutional investors and hedge funds held shares of Eagle Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Nantahala Capital Management, LLC: 1.96 M
AIGH Capital Management LLC: 1.21 M
CITIGROUP INC: 1 M
AQR CAPITAL MANAGEMENT LLC: 696,797
VANGUARD GROUP INC: 564,396
BlackRock Inc.: 352,762
-
What percentage of Eagle Pharmaceuticals, Inc. stock is owned by institutional investors?
75.40% of Eagle Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at EGRX ?
Institutional investors have bought a total of 13.00 M shares in the last 24 months. This purchase volume represents approximately $48.24 M in transactions.